| Two-dimensional liquid chromatography-mass spectrometry (2DLC-MS) platform to conduct an in-depth lipidomic analysis of liver and brain tissues from fat-1 transgenic mice exposed to ethanol. (ST004300) |
University of Louisville |
Mus musculus |
ESI |
1117 |
| Food intake-independent metabolic alterations in cachectic C26 mice compared to non-cachectic C26 mice (ST004321) |
Harvard School of Public Health |
Mus musculus |
ESI |
57 |
| Plasma lipidomics characterization of mouse models of Down syndrome Dp16 and Dp16-2xIfnrs versus WT mice (ST004412) |
University of Colorado Anschutz Medical Campus |
Mus musculus |
ESI |
59 |
| Bacteria-derived 3-hydroxydodecanoic acid induces a potent anti-tumor immune response via GPR84 receptor (ST003655) |
Universitätsspital Zürich |
Mus musculus; Homo sapiens |
MALDI |
48 |
| Role of cilia in mitochondrial function (ST002809) |
Medical University of South Carolina |
Mus musculus;Canis lupus familiaris |
ESI |
317 |
| Temperature change elicits lipidome adaptation in the simple organisms Mycoplasma mycoides and JCVI-syn3B (ST003251) |
TU Dresden |
Mycoplasma mycoides, Minimal cell JCVI-syn3B |
ESI |
185 |
| White adipose tissue remodeling in Little Brown Myotis (Myotis lucifugus) with white-nose syndrome (ST003437) |
Georgetown University |
Myotis lucifugus |
ESI |
690 |
| White-nose syndrome disrupts the splenic lipidome of little brown bats (Myotis lucifugus) at early disease stages (ST002304) |
Georgetown University |
Myotis lucifugus |
ESI |
261 |
| M-CMV infected Nicotiana tabacum (ST000497) |
Chinese Academy of Inspection and Quarantine |
Nicotiana tabacum |
ESI |
22 |
| Modulation of blood metabolites by dietary ?–glucan in rainbow trout (Oncorhynchus mykiss) - Serum lipid concentrations (ST002278) |
Helmholtz Centre for Environmental Research |
Oncorhynchus mykiss |
ESI |
144 |
| Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South Africa (part-I) (ST001052) |
South East Center for Integrated Metabolomics |
Oreochromis mossambicus |
ESI |
491 |
| Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South Africa (part-II) (ST001059) |
South East Center for Integrated Metabolomics |
Oreochromis mossambicus |
ESI |
737 |
| Rabbit Plasma Lipidomics with high fat diet and treatment (ST000781) |
University of Michigan |
Oryctolagus cuniculus |
ESI |
458 |
| Rice Infection Study (ST000007) |
University of California, Davis |
Oryza sativa Japonica Group |
EI |
29 |
| Lipodomics and Gestational bisphenol A (BPA) exposure (ST000686) |
University of Michigan |
Ovis aries |
ESI |
318 |
| Lipidomics of Newborn Heart Tissue Exposed to Excess Maternal Cortisol in Late Gestation (part-1) (ST001106) |
University of Florida |
Ovis aries |
ESI |
294 |
| Lipidomics of Near-Term Fetal and Newborn Sheep Cardiac Tissue (part-II) (ST001061) |
University of Florida |
Ovis aries |
ESI |
294 |
| Maternal Hypoxemia and oxidative stress in the fetus, newborn, and adult. exercise training for peripheral artery disease (part II) (ST000873) |
University of California, Davis |
Ovis aries |
ESI |
77 |
| Maternal Hypoxemia and oxidative stress in the fetus, newborn, and adult. exercise training for peripheral artery disease (ST000872) |
University of California, Davis |
Ovis aries |
ESI |
58 |
| Maternal Hypoxemia and Oxidative Stress (ST002043) |
Loma Linda University School of Medicine |
Ovis aries |
EI |
28 |
| Rumenomics: Evaluation of rumen metabolites content on phenotypical features of sheep (ST002908) |
Purdue University |
Ovis aries |
ESI |
122 |
| Untargeted metabolomics of rhizosphere soil from 4-years Panax ginseng that was treated with endo-borneol under field condition (ST003307) |
Yunnan University |
Panax ginseng |
ESI |
146 |
| Guinea Grass Untargeted Metabolomic Profiling (ST001071) |
University of Illinois Urbana-Champaign |
Panicum maximum(Megathyrsis maximus (Jacq.)) |
EI |
37 |
| Maternal obesity alters offspring liver and skeletal muscle metabolism in early post-puberty despite maintaining a normal post-weaning dietary lifestyle (ST002254) |
Wake Forest School of Medicine |
Papio hamadryas |
EI |
60 |
| High Resolution GC-MS Metabolomics of Non-Human Primate Serum (ST000972) |
Wake Forest School of Medicine |
Papio hamadryas |
EI |
55 |
| Optimization of Imputation Strategies for High-Resolution Gas Chromatography-Mass Spectrometry (HR GC-MS) Metabolomics Data (ST002132) |
Wake Forest School of Medicine |
Papio hamadryas |
EI |
70 |
| Metabolic Profiling of Date Palm Fruits (ST000508) |
Weill Cornell Medicine, Qatar |
Phoenix dactylifera |
ESI |
71 |
| Metabolic Profiling of Date Palm Fruits (part II) (ST000867) |
Weill Cornell Medicine, Qatar |
Phoenix dactylifera |
ESI |
71 |
| Needle leachates of Pinus koraiensis from May to September (ST003309) |
Yunnan University |
Pinus koraiensis |
EI |
78 |
| Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites (ST002698) |
Peter Doherty Institute for Infection and Immunity |
Plasmodium berghei |
ESI |
98 |
| Determination of mode of action of anti-malalrial drugs using untargeted metabolomics (ST001033) |
Monash University |
Plasmodium falciparum |
ESI |
135 |
| Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum (ST001175) |
Monash University |
Plasmodium falciparum |
ESI |
168 |
| Retargeting azithromycin-like compounds as antimalarials with dual modality (ST001315) |
Monash University |
Plasmodium falciparum |
ESI |
114 |
| Validating the role of the arginine to proline biosynthetic pathway in the APR (ST004233) |
Broad Institute of MIT and Harvard |
Plasmodium falciparum |
ESI |
27 |
| Metabolomics-based screening of the Malaria Box reveals both novel and established mechanisms of action (ST000414) |
Monash Institute of Pharmaceutical Sciences |
Plasmodium falciparum |
ESI |
148 |
| On-target, dual aminopeptidase inhibition provides cross-species antimalarial activity (ST003144) |
Monash University |
Plasmodium falciparum |
ESI |
190 |
| Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells (ST003565) |
Monash University |
Plasmodium falciparum |
ESI |
287 |
| Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 1) (ST002106) |
Monash University |
Plasmodium falciparum |
ESI |
113 |
| Multi-omics based identification of specific biochemical changes associated with PfKelch13-mutant artemisinin resistant Plasmodium (ST000546) |
Monash University |
Plasmodium falciparum |
ESI |
146 |
| Multi-“omics” analysis reveals the orphan P. falciparum protein kinase PfPK8 regulates multi-gene family expression (ST002926) |
Monash University |
Plasmodium falciparum |
ESI |
128 |
| Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria (ST002792) |
Monash University |
Plasmodium falciparum |
ESI |
189 |
| Targeting malaria parasites with novel derivatives of azithromycin (ST002309) |
Monash University |
Plasmodium falciparum |
ESI |
113 |
| Labeled amino acid uptake from multiplexed isotope media (ST004239) |
Broad Institute of MIT and Harvard |
Plasmodium falciparum |
ESI |
27 |
| Elucidating the source of elevated proline in APR parasites (ST004222) |
Broad Institute of MIT and Harvard |
Plasmodium falciparum |
ESI |
27 |
| Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 (ST003179) |
Monash University |
Plasmodium falciparum |
ESI |
286 |
| New class of heterospirocyclic compounds present strong and rapid activity against artemisinin- and multidrug-resistant P. falciparum parasites (ST003160) |
Monash University |
Plasmodium falciparum |
ESI |
166 |
| PfApiAT2 loss of function leads to Adaptive Proline Response (APR) (ST004240) |
Broad Institute of MIT and Harvard |
Plasmodium falciparum |
ESI |
27 |
| Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) (ST002108) |
Monash University |
Plasmodium falciparum |
ESI |
212 |
| Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 2) (ST002107) |
Monash University |
Plasmodium falciparum |
ESI |
152 |
| Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites (ST001201) |
Monash University |
Plasmodium falciparum;Homo sapiens |
ESI |
167 |